SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001328143-21-000042
Filing Date
2021-05-10
Accepted
2021-05-10 16:02:03
Documents
68
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adms-20210331.htm   iXBRL 10-Q 1243267
2 EX-10.1 adms10qq12021ex101.htm EX-10.1 113771
3 EX-10.2 adms_10qq12021ex102.htm EX-10.2 85090
4 EX-31.1 adms10qq12021ex311.htm EX-31.1 11584
5 EX-31.2 adms10qq12021ex312.htm EX-31.2 11925
6 EX-32.1 adms10qq12021ex321.htm EX-32.1 8831
  Complete submission text file 0001328143-21-000042.txt   5611197

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20210331.xsd EX-101.SCH 35436
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20210331_cal.xml EX-101.CAL 72636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20210331_def.xml EX-101.DEF 198247
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20210331_lab.xml EX-101.LAB 481341
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20210331_pre.xml EX-101.PRE 309947
12 EXTRACTED XBRL INSTANCE DOCUMENT adms-20210331_htm.xml XML 755497
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 21906973
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences